Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Construction in Progress (2016 - 2017)

Historic Construction in Progress for Immucell (ICCC) over the last 6 years, with Q3 2017 value amounting to $17.1 million.

  • Immucell's Construction in Progress rose 154734.13% to $17.1 million in Q3 2017 from the same period last year, while for Sep 2017 it was $17.1 million, marking a year-over-year increase of 154734.13%. This contributed to the annual value of $3.7 million for FY2016, which is 24053.16% up from last year.
  • Immucell's Construction in Progress amounted to $17.1 million in Q3 2017, which was up 154734.13% from $13.3 million recorded in Q2 2017.
  • Immucell's Construction in Progress' 5-year high stood at $17.1 million during Q3 2017, with a 5-year trough of $4137.0 in Q1 2013.
  • In the last 5 years, Immucell's Construction in Progress had a median value of $588408.0 in 2015 and averaged $2.7 million.
  • As far as peak fluctuations go, Immucell's Construction in Progress crashed by 9646.56% in 2016, and later surged by 3979698.15% in 2017.
  • Quarter analysis of 5 years shows Immucell's Construction in Progress stood at $9600.0 in 2013, then soared by 13136.17% to $1.3 million in 2014, then dropped by 14.62% to $1.1 million in 2015, then soared by 240.53% to $3.7 million in 2016, then skyrocketed by 363.16% to $17.1 million in 2017.
  • Its last three reported values are $17.1 million in Q3 2017, $13.3 million for Q2 2017, and $7.5 million during Q1 2017.